Andrew R. Belch

Department of Oncology, University of Alberta

Affiliated withUniversity of Alberta Cross Cancer Institute

Research Area

Biography

Andrew R. Belch has not added Biography.
If you are Andrew R. Belch and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 16	2014

Other Publications

Article	Year
Intraclonal homogeneity of clonotypic immunoglobulin M and diversity of nonclinical post-switch isotypes in multiple myeloma: insights into the evolution of the myeloma clone. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 11839670	2002
Leukemic B cells clonally identical to myeloma plasma cells are myelomagenic in NOD/SCID mice. Experimental hematology\| PubMed ID: 11882359	2002
CD20-directed serotherapy in patients with multiple myeloma: biologic considerations and therapeutic applications. Journal of immunotherapy (Hagerstown, Md. : 1997)\| PubMed ID: 11924912	2002
Clonotypic myeloma cells able to xenograft myeloma to nonobese diabetic severe combined immunodeficient mice copurify with CD34 (+) hematopoietic progenitors. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 12374689	2002
Differential expression of human equilibrative nucleoside transporter 1 (hENT1) protein in the Reed-Sternberg cells of Hodgkin's disease. Leukemia & lymphoma\| PubMed ID: 12389626	2002
In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression. Blood\| PubMed ID: 12393535	2003
The malignant clone in Waldenstrom's macroglobulinemia. Seminars in oncology\| PubMed ID: 12720122	2003
Abnormal expression of hyaluronan synthases in patients with Waldenstrom's macroglobulimenia. Seminars in oncology\| PubMed ID: 12720129	2003
Clonotypic IgM V/D/J sequence analysis in Waldenstrom macroglobulinemia suggests an unusual B-cell origin and an expansion of polyclonal B cells in peripheral blood. Blood\| PubMed ID: 14764523	2004
RHAMM expression and isoform balance predict aggressive disease and poor survival in multiple myeloma. Blood\| PubMed ID: 15105292	2004
Association between exercise and quality of life in multiple myeloma cancer survivors. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer\| PubMed ID: 15322968	2004
Results of a multicenter randomized phase II trial of thalidomide and prednisone maintenance therapy for multiple myeloma after autologous stem cell transplant. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 15623591	2004
Overexpression of transcripts originating from the MMSET locus characterizes all t(4;14)(p16;q32)-positive multiple myeloma patients. Blood\| PubMed ID: 15677557	2005
Receptor for hyaluronan-mediated motility correlates with centrosome abnormalities in multiple myeloma and maintains mitotic integrity. Cancer research\| PubMed ID: 15705883	2005
Intronic splicing of hyaluronan synthase 1 (HAS1): a biologically relevant indicator of poor outcome in multiple myeloma. Blood\| PubMed ID: 15731173	2005
Origins of Waldenstrom's macroglobulinemia: does it arise from an unusual B-cell precursor? Clinical lymphoma\| PubMed ID: 15794851	2005
Potential impact of a single nucleotide polymorphism in the hyaluronan synthase 1 gene in Waldenstrom's macroglobulinemia. Clinical lymphoma\| PubMed ID: 15794859	2005
Sensitive detection using microfluidics technology of single cell PCR products from high and low abundance IgH VDJ templates in multiple myeloma. Journal of immunological methods\| PubMed ID: 16150455	2005
SSX cancer testis antigens are expressed in most multiple myeloma patients: co-expression of SSX1, 2, 4, and 5 correlates with adverse prognosis and high frequencies of SSX-positive PCs. Journal of immunotherapy (Hagerstown, Md. : 1997)\| PubMed ID: 16224274	2005
Impaired class switch recombination (CSR) in Waldenstrom macroglobulinemia (WM) despite apparently normal CSR machinery. Blood\| PubMed ID: 16317092	2006
Understanding the determinants of exercise intentions in multiple myeloma cancer survivors: an application of the theory of planned behavior. Cancer nursing\| PubMed ID: 16783115	2006
Ten years and counting: so what do we know about t(4;14)(p16;q32) multiple myeloma. Leukemia & lymphoma\| PubMed ID: 17107900	2006
Molecular characterization of Waldenstrom's macroglobulinemia reveals frequent occurrence of two B-cell clones having distinct IgH VDJ sequences. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 17404080	2007
Concordant but not discordant bone marrow involvement in diffuse large B-cell lymphoma predicts a poor clinical outcome independent of the International Prognostic Index. Blood\| PubMed ID: 17475910	2007
Microfluidic chips for detecting the t(4;14) translocation and monitoring disease during treatment using reverse transcriptase-polymerase chain reaction analysis of IgH-MMSET hybrid transcri... The Journal of molecular diagnostics : JMD\| PubMed ID: 17591936	2007
The selective Aurora B kinase inhibitor AZD1152 is a potential new treatment for multiple myeloma. British journal of haematology\| PubMed ID: 18076711	2008
A unique three-dimensional model for evaluating the impact of therapy on multiple myeloma. Blood\| PubMed ID: 18535198	2008
Analysis of clonotypic switch junctions reveals multiple myeloma originates from a single class switch event with ongoing mutation in the isotype-switched progeny. Blood\| PubMed ID: 18577707	2008
Treatment of relapsed and refractory myeloma. Leukemia & lymphoma\| PubMed ID: 18608859	2008
Inherited and acquired variations in the hyaluronan synthase 1 (HAS1) gene may contribute to disease progression in multiple myeloma and Waldenstrom macroglobulinemia. Blood\| PubMed ID: 18815290	2008
Altered expression of fibronectin and collagens I and IV in multiple myeloma and monoclonal gammopathy of undetermined significance. The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society\| PubMed ID: 19001640	2009
High response rate to bortezomib with or without dexamethasone in patients with relapsed or refractory multiple myeloma: results of a global phase 3b expanded access program. British journal of haematology\| PubMed ID: 19036114	2009
Genetic abnormalities in Waldenström's macroglobulinemia. Clinical lymphoma & myeloma\| PubMed ID: 19362966	2009
Promiscuity of translocation partners in multiple myeloma. Journal of cellular biochemistry\| PubMed ID: 20127714	2010
Multiple myeloma may include microvessel endothelial cells of malignant origin. Leukemia & lymphoma\| PubMed ID: 20233053	2010
In a patient with biclonal Waldenstrom macroglobulinemia only one clone expands in three-dimensional culture and includes putative cancer stem cells. Leukemia & lymphoma\| PubMed ID: 21133724	2011
Expression, adverse prognostic significance and therapeutic small molecule inhibition of Polo-like kinase 1 in multiple myeloma. Leukemia research\| PubMed ID: 21816470	2011
Multiple Myeloma Includes Phenotypically Defined Subsets of Clonotypic CD20+ B Cells that Persist During Treatment with Rituximab. Clinical medicine. Oncology\| PubMed ID: 21892289	2008
Differential positioning and close spatial proximity of translocation-prone genes in nonmalignant B-cells from multiple myeloma patients. Genes, chromosomes & cancer\| PubMed ID: 22489023	2012
In multiple myeloma, bone-marrow lymphocytes harboring the same chromosomal abnormalities as autologous plasma cells predict poor survival. American journal of hematology\| PubMed ID: 22495885	2012
In non-transplant patients with multiple myeloma, the pre-treatment level of clonotypic cells predicts event-free survival. Molecular cancer\| PubMed ID: 23083101	2012
Impact of age on outcomes after initial therapy with chemotherapy and different chemoimmunotherapy regimens in patients with chronic lymphocytic leukemia: results of sequential cancer and le... Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 23233702	2013
Alteration of introns in a hyaluronan synthase 1 (HAS1) minigene convert Pre-mRNA [corrected] splicing to the aberrant pattern in multiple myeloma (MM): MM patients harbor similar changes. PloS one\| PubMed ID: 23301075	2013
Differential nuclear organization of translocation-prone genes in nonmalignant B cells from patients with t(14;16) as compared with t(4;14) or t(11;14) myeloma. Genes, chromosomes & cancer\| PubMed ID: 23460268	2013
Aberrant splicing, hyaluronan synthases and intracellular hyaluronan as drivers of oncogenesis and potential drug targets. Current cancer drug targets\| PubMed ID: 23517594	2013
The systemic cytokine environment is permanently altered in multiple myeloma. PloS one\| PubMed ID: 23544044	2013
Frequent occurrence of highly expanded but unrelated B-cell clones in patients with multiple myeloma. PloS one\| PubMed ID: 23724106	2013